Led by Jean-Nicolas DUMEZ

December 2023 - December 2027

Financials: 570 525 €  (ANR PRC - ANR-23-CE29-0013)

The SOFTNMR project aims to provide a wealth of information on organic chemical reactions, through the development of sensitive methods for the analysis of reaction mixtures, based on flow nuclear magnetic resonance (NMR) spectroscopy.

Led by Eléna ISHOW

2022 – 2025

Financials: 519 000 € (ANR PRC)

The pluridisciplinary AZOTICS project, gathering teams of chemists, physicists and biologists, targets two main objectives: the first one, quite fundamental, focusing on a better understanding of optical, thermal and mechanical energy exchanges at the nanoscale; the second one, more applied, oriented toward the development of multimodal tools for real-time monitoring of inflammatory processes.

Led by Estelle LEBEGUE

January 2022 – December 2025

Financials: 254 272 € (ANR JCJC - ANR-21-CE42-0007-01)

The ELIPOX research project (Electrochemistry of redox liposome nano-impacts for bacterial toxins sensing) aims to detect with a high sensibility the presence of bacterial toxins thanks to the electrochemistry of redox liposome nano-impacts.

Led by François-Xavier FELPIN

December 2021 - December 2025

Financials: 384 496 € (ANR-21-CE07-0056)

The DigitalChem project will develop the world's first workflow platform for autonomous screening and optimization of reaction conditions.

Led by Vincent COEFFARD

September 2019 - Mars 2023

Financials: 182 809 € (ANR PRC - ANR-18-CE07-0013)

The aim of the CAROS project is to develop novel photosensitizers able to generate, store and selectively release singlet oxygen for applications in antibacterial photodynamic therapy (PTDA).

Led by Adèle LAURENT

December 2018 - November 2022

Financials: 172 629 € (ANR JCJC)

The InducedFluo project led by Adèle LAURENT aims to characterize a new class of fluorescent protein using theoretical chemistry approches in order to extend its field of application.

Led by Sébastien GOUIN

September 2017 - September 2020

Financials: 377 278 € (ANR-17-CE07-0028)

HICARE project is based on an unprecedented approach for reaching high affinities and selectivities for sialidase enzymes expressed by bacteria and parasites. Many sialidases of biological interest possess carbohydrate-binding modules (CBM) in close proximity of the catalytic site (CAT). They functions as anchoring points to the targeted glycans, increasing the catalytic efficiency of the system. The aim of HICARE is to develop multivalent inhibitors targeting both the CAT and CBM modules.